Hørsholm, Denmark

Disa Tehler

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Disa Tehler. Retrieved from https://idiyas.com/inventor/disa-tehler-azcyqeom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Disa Tehler: Innovator in Neurological Treatments

Introduction

Disa Tehler is a prominent inventor based in Hørsholm, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic solutions for neurological disorders.

Latest Patents

Disa Tehler holds a patent for "Oligonucleotide agonists targeting progranulin." This invention relates to oligonucleotides that up-regulate or restore the expression of progranulin in cells. The application of this technology is aimed at treating neurological disorders and conditions associated with progranulin haploinsufficiency. He has 1 patent to his name.

Career Highlights

Tehler is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work focuses on innovative approaches to address complex medical challenges, particularly in the realm of neurological health.

Collaborations

Throughout his career, Disa Tehler has collaborated with notable professionals in the field, including Ravi Jagasia and Lars Joenson. These partnerships have enhanced the development and application of his inventions.

Conclusion

Disa Tehler's contributions to biotechnology and his innovative patent for oligonucleotide agonists highlight his commitment to advancing medical science. His work continues to pave the way for new treatments in the field of neurology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…